Literature DB >> 5117875

Determination of hydroxyurea in mammalian tissues and blood.

E Fabricius, F Rajewsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5117875

Source DB:  PubMed          Journal:  Rev Eur Etud Clin Biol        ISSN： 0035-3019


× No keyword cloud information.
  17 in total

1.  Analysis of hydroxyurea in capsules and aqueous solution and stability study with capillary gas chromatography and thermionic (N-P) specific detection.

Authors:  A el-Yazigi; S al-Rawithi
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

Review 2.  Pharmacokinetics and pharmacodynamics of hydroxyurea.

Authors:  P R Gwilt; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

3.  Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia.

Authors:  Russell E Ware; Jenny M Despotovic; Nicole A Mortier; Jonathan M Flanagan; Jin He; Matthew P Smeltzer; Amy C Kimble; Banu Aygun; Song Wu; Thad Howard; Alex Sparreboom
Journal:  Blood       Date:  2011-08-29       Impact factor: 22.113

4.  Synchronization of stimulated urothelial proliferation. Experimental models for cell cycle specific testing of bladder carcinogens.

Authors:  E Kunze; J Weber; P Gellhar; T Graewe; S Scherber
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Proliferative parameters of mammalian cell systms and their rôle in tumor growth and carcinogenesis.

Authors:  M F Rajewsky
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

6.  [Studies on synchronisation in vivo: temporary inhibition of DNA synthesis in normal and malignant mammalian cell systems with hydroxyurea].

Authors:  M F Rajewsky; D F Hülser; E Fabricius
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

7.  Phase 1 study of high-dose hydroxyurea in lung cancer.

Authors:  D Veale; B M Cantwell; N Kerr; A Upfold; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  Population pharmacokinetics of hydroxyurea in cancer patients.

Authors:  W G Tracewell; D L Trump; W P Vaughan; D C Smith; P R Gwilt
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  [Partial synchronization of tumor cells in vivo with hydroxyurea (author's transl)].

Authors:  R Hartenstein; K Pfundmair; K Possinger
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977

10.  A phase I trial of high-dose continuous-infusion hydroxyurea.

Authors:  D C Smith; W P Vaughan; P R Gwilt; D L Trump
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.